Cdc7-IN-12

• UNSPSC Description:

  Cdc7-IN-12 (compound 1) is a potent CDC7 inhibitor with an IC50 of 50 of 100-1000 nM in COLO205 cells. Cdc7-IN-12 has the potential for the research of cancer[1].

• Target Antigen:

  CDK

• Type:

  Reference compound

• Related Pathways:

  Cell Cycle/DNA Damage

• Applications:

  Cancer-Kinase/protease

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/cdc7-in-12.html

• Solubility:

  10 mM in DMSO

• Smiles:

  CC1=C2CCCOC3=C(SC(C(N1)=O)=C23)C4=CC=NC=C4

• Molecular Weight:

  298.36

• References & Citations:

  [1]Huang XIanhai, et al. Heterocyclic pericondensed cdc7 kinase inhibitors for the treatment of cancer. WO2022055963A1.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2764865-33-8